Medical Marijuana, Inc. announced that the Company’s portfolio company Kannalife, Inc., a biopharmaceutical company leading innovation in research, development and discovery of natural and novel biomimetic cannabinoid therapeutic agents, published its research findings around Chemotherapy-Induced Peripheral Neuropathy in the Journal of Molecular Neuroscience.
May 23, 2019
· 5 min read